JP2011524516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011524516A5 JP2011524516A5 JP2011509999A JP2011509999A JP2011524516A5 JP 2011524516 A5 JP2011524516 A5 JP 2011524516A5 JP 2011509999 A JP2011509999 A JP 2011509999A JP 2011509999 A JP2011509999 A JP 2011509999A JP 2011524516 A5 JP2011524516 A5 JP 2011524516A5
- Authority
- JP
- Japan
- Prior art keywords
- neurotrophin
- trkc
- fragment
- cancer
- biopsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5505208P | 2008-05-21 | 2008-05-21 | |
| US61/055.052 | 2008-05-21 | ||
| PCT/EP2009/056253 WO2009141441A1 (en) | 2008-05-21 | 2009-05-22 | Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014253505A Division JP2015092170A (ja) | 2008-05-21 | 2014-12-15 | ＮＴ−３：ＴｒｋＣ結合の阻害および神経芽腫などの癌の処置へのその適用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011524516A JP2011524516A (ja) | 2011-09-01 |
| JP2011524516A5 true JP2011524516A5 (https=) | 2012-07-12 |
| JP5758289B2 JP5758289B2 (ja) | 2015-08-05 |
Family
ID=40941707
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509999A Expired - Fee Related JP5758289B2 (ja) | 2008-05-21 | 2009-05-22 | ＮＴ−３：ＴｒｋＣ結合の阻害および神経芽腫などの癌の処置へのその適用 |
| JP2014253505A Pending JP2015092170A (ja) | 2008-05-21 | 2014-12-15 | ＮＴ−３：ＴｒｋＣ結合の阻害および神経芽腫などの癌の処置へのその適用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014253505A Pending JP2015092170A (ja) | 2008-05-21 | 2014-12-15 | ＮＴ−３：ＴｒｋＣ結合の阻害および神経芽腫などの癌の処置へのその適用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20110229485A1 (https=) |
| EP (1) | EP2294416A1 (https=) |
| JP (2) | JP5758289B2 (https=) |
| CA (1) | CA2724830A1 (https=) |
| WO (1) | WO2009141441A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6929231B2 (ja) * | 2015-05-29 | 2021-09-01 | イグナイタ インコーポレイテッド | Ｒｔｋ突然変異細胞を有する患者を処置するための組成物及び方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5348856A (en) * | 1991-07-08 | 1994-09-20 | E. R. Squibb & Sons, Inc. | DNA encoding TRKC protein |
| US5789187A (en) * | 1992-08-27 | 1998-08-04 | Worcester Foundation For Experimental Biology | Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner |
| US20040058416A1 (en) * | 1994-03-18 | 2004-03-25 | Presta Leonard G. | Human trk receptors and neurotrophic factor inhibitors |
| US6008003A (en) * | 1997-10-28 | 1999-12-28 | Promega Corporation | Non-invasive diagnostic method for interstitial cystitis and bladder cancer |
| WO1999040103A1 (en) * | 1998-02-10 | 1999-08-12 | The Children's Medical Center Corporation | Nt-3 and medulloblastoma |
| US6548062B2 (en) * | 2000-02-29 | 2003-04-15 | Cephalon, Inc. | Method of treating cancer with anti-neurotrophin agents |
| ATE446366T1 (de) * | 2000-06-22 | 2009-11-15 | Genentech Inc | Agonistische monoklonale antikörper gegen trkc |
| JP2003231687A (ja) * | 2002-02-04 | 2003-08-19 | Japan Tobacco Inc | ピラゾリル縮合環化合物及びその医薬用途 |
| CN101218229A (zh) * | 2005-05-05 | 2008-07-09 | 阿斯利康(瑞典)有限公司 | 吡唑基-氨基取代的嘧啶及其在癌症治疗中的应用 |
| WO2007099133A1 (en) * | 2006-02-28 | 2007-09-07 | Centre National De La Recherche Scientifique (Cnrs) | Screening for anti-cancer compounds using netrin-1 activity |
| WO2008045627A2 (en) * | 2006-10-06 | 2008-04-17 | Irm Llc | Protein kinase inhibitors and methods for using thereof |
-
2009
- 2009-05-22 JP JP2011509999A patent/JP5758289B2/ja not_active Expired - Fee Related
- 2009-05-22 US US12/993,663 patent/US20110229485A1/en not_active Abandoned
- 2009-05-22 WO PCT/EP2009/056253 patent/WO2009141441A1/en not_active Ceased
- 2009-05-22 CA CA2724830A patent/CA2724830A1/en not_active Abandoned
- 2009-05-22 EP EP09749931A patent/EP2294416A1/en not_active Withdrawn
-
2013
- 2013-12-19 US US14/134,869 patent/US20140186364A1/en not_active Abandoned
-
2014
- 2014-12-15 JP JP2014253505A patent/JP2015092170A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mercer et al. | Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF | |
| Chen et al. | Hepatoma‐derived growth factor regulates breast cancer cell invasion by modulating epithelial–mesenchymal transition | |
| Prosniak et al. | Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers | |
| Cui et al. | R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling | |
| Wang et al. | Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma | |
| Wu et al. | MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression | |
| Cornelius et al. | Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma | |
| Zheng et al. | Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis | |
| WO2013009655A3 (en) | Uses of labeled hsp90 inhibitors | |
| JP2008535494A5 (https=) | ||
| WO2009029591A3 (en) | Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods | |
| JP2016536330A5 (https=) | ||
| KR20150014919A (ko) | 암 전이의 예후 및 치료 방법 | |
| JP2015533788A5 (https=) | ||
| JP2012522756A5 (https=) | ||
| KR20160061424A (ko) | 유방암으로부터 기원하는 골의 전이성 암의 예후 및 치료 방법 | |
| CN104995313A (zh) | 使用c-maf的前列腺癌转移的诊断、预后和治疗的方法 | |
| Lee et al. | Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression | |
| KR20190021252A (ko) | c-MAF 상태에 기초한 유방암의 치료 | |
| Nassar et al. | Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesis | |
| JP2009527485A5 (https=) | ||
| CA2807104C (en) | Bard1 isoforms in lung and colorectal cancer and use thereof | |
| Li et al. | PKMYT1 promotes epithelial-mesenchymal transition process in triple-negative breast cancer by activating notch signaling | |
| Körner et al. | CCK2 receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours | |
| JP2008525479A5 (https=) |